Polynovo Stock

Polynovo PP&E per Employee

The PP&E per Employee of Polynovo (PNV.AX) as of Aug 23, 2026 is 587,984.62 AUD. In the previous year, PP&E per Employee was 371,784.62 AUD — a change of 58.15% (higher).

PP&E per Employee

587,984.62AUD

YoY

58.15%

Last updated:

PP&E per Employee of Polynovo is 2026 587,984.62 AUD. PP&E per Employee of Polynovo was 2025 371,784.62 AUD. It decreases by 58.15% higher compared to the previous year.

The Polynovo PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2018
17,533.85 AUD
Jan 1, 2019
92,433.85 AUD
Jan 1, 2020
254,413.85 AUD
Jan 1, 2021
304,972.31 AUD
Jan 1, 2022
257,716.92 AUD
Jan 1, 2023
359,501.54 AUD
Jan 1, 2024
371,784.62 AUD
Jan 1, 2025
587,984.62 AUD
The Polynovo PP&E per Employee history
YEARPP&E per EmployeeYoY
587,984.62AUD+58.15%
371,784.62AUD+3.42%
359,501.54AUD+39.49%
257,716.92AUD-15.49%
304,972.31AUD+19.87%
254,413.85AUD+175.24%
92,433.85AUD+427.17%
17,533.85AUD-21.53%
22,344.62AUD+46.31%
15,272.31AUD-1.49%
15,503.08AUD+6.07%
14,615.38AUD
Access this data via the Eulerpool API

Polynovo Stock analysis

What does Polynovo do? Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polynovo stock

PP&E per Employee of Polynovo is 587,984.62 AUD in 2026.

PP&E per Employee of Polynovo changed from 371,784.62 AUD to 587,984.62 AUD, representing a 58.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Polynovo since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Polynovo historically and in real time.

Access this data via the Eulerpool API

Workforce — Polynovo

All Key Metrics — Polynovo